JP3770588B2 - Topical skin preparation - Google Patents
Topical skin preparation Download PDFInfo
- Publication number
- JP3770588B2 JP3770588B2 JP2001061534A JP2001061534A JP3770588B2 JP 3770588 B2 JP3770588 B2 JP 3770588B2 JP 2001061534 A JP2001061534 A JP 2001061534A JP 2001061534 A JP2001061534 A JP 2001061534A JP 3770588 B2 JP3770588 B2 JP 3770588B2
- Authority
- JP
- Japan
- Prior art keywords
- skin
- external preparation
- acid
- derivatives
- carotenoid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002360 preparation method Methods 0.000 title claims description 32
- 230000000699 topical effect Effects 0.000 title description 2
- -1 polyoxyethylene Polymers 0.000 claims description 29
- 235000021466 carotenoid Nutrition 0.000 claims description 26
- 150000001747 carotenoids Chemical class 0.000 claims description 26
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 12
- 239000004359 castor oil Substances 0.000 claims description 12
- 235000019438 castor oil Nutrition 0.000 claims description 12
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 12
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 claims description 11
- 150000004492 retinoid derivatives Chemical class 0.000 claims description 10
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 claims description 8
- 235000013793 astaxanthin Nutrition 0.000 claims description 8
- 239000001168 astaxanthin Substances 0.000 claims description 8
- 229940022405 astaxanthin Drugs 0.000 claims description 8
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 claims description 7
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 claims description 6
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 5
- FDSDTBUPSURDBL-LOFNIBRQSA-N canthaxanthin Chemical compound CC=1C(=O)CCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)CCC1(C)C FDSDTBUPSURDBL-LOFNIBRQSA-N 0.000 claims description 4
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 3
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims description 3
- 235000013734 beta-carotene Nutrition 0.000 claims description 3
- 239000011648 beta-carotene Substances 0.000 claims description 3
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims description 3
- 229960002747 betacarotene Drugs 0.000 claims description 3
- 229940108325 retinyl palmitate Drugs 0.000 claims description 3
- 235000019172 retinyl palmitate Nutrition 0.000 claims description 3
- 239000011769 retinyl palmitate Substances 0.000 claims description 3
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims description 3
- DMASLKHVQRHNES-UPOGUZCLSA-N (3R)-beta,beta-caroten-3-ol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C DMASLKHVQRHNES-UPOGUZCLSA-N 0.000 claims description 2
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 claims description 2
- VYIRVAXUEZSDNC-TXDLOWMYSA-N (3R,3'S,5'R)-3,3'-dihydroxy-beta-kappa-caroten-6'-one Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC(=O)[C@]1(C)C[C@@H](O)CC1(C)C VYIRVAXUEZSDNC-TXDLOWMYSA-N 0.000 claims description 2
- QHNVWXUULMZJKD-UHFFFAOYSA-N 3,4-didehydroretinal Chemical compound O=CC=C(C)C=CC=C(C)C=CC1=C(C)C=CCC1(C)C QHNVWXUULMZJKD-UHFFFAOYSA-N 0.000 claims description 2
- VYIRVAXUEZSDNC-LOFNIBRQSA-N Capsanthyn Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC(=O)C2(C)CC(O)CC2(C)C VYIRVAXUEZSDNC-LOFNIBRQSA-N 0.000 claims description 2
- 239000004212 Cryptoxanthin Substances 0.000 claims description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 claims description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims description 2
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 claims description 2
- OOUTWVMJGMVRQF-DOYZGLONSA-N Phoenicoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)C(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)C(=O)CCC2(C)C OOUTWVMJGMVRQF-DOYZGLONSA-N 0.000 claims description 2
- 239000004213 Violaxanthin Substances 0.000 claims description 2
- SZCBXWMUOPQSOX-LOFNIBRQSA-N Violaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C12OC1(C)CC(O)CC2(C)C)C=CC=C(/C)C=CC34OC3(C)CC(O)CC4(C)C SZCBXWMUOPQSOX-LOFNIBRQSA-N 0.000 claims description 2
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 claims description 2
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 claims description 2
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 claims description 2
- 235000002360 beta-cryptoxanthin Nutrition 0.000 claims description 2
- DMASLKHVQRHNES-ITUXNECMSA-N beta-cryptoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CCCC2(C)C DMASLKHVQRHNES-ITUXNECMSA-N 0.000 claims description 2
- 235000012682 canthaxanthin Nutrition 0.000 claims description 2
- 239000001659 canthaxanthin Substances 0.000 claims description 2
- 229940008033 canthaxanthin Drugs 0.000 claims description 2
- WRANYHFEXGNSND-LOFNIBRQSA-N capsanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC(=O)C2(C)CCC(O)C2(C)C WRANYHFEXGNSND-LOFNIBRQSA-N 0.000 claims description 2
- 235000018889 capsanthin Nutrition 0.000 claims description 2
- 235000019244 cryptoxanthin Nutrition 0.000 claims description 2
- SJWWTRQNNRNTPU-ABBNZJFMSA-N fucoxanthin Chemical compound C[C@@]1(O)C[C@@H](OC(=O)C)CC(C)(C)C1=C=C\C(C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)C(=O)C[C@]1(C(C[C@H](O)C2)(C)C)[C@]2(C)O1 SJWWTRQNNRNTPU-ABBNZJFMSA-N 0.000 claims description 2
- AQLRNQCFQNNMJA-UHFFFAOYSA-N fucoxanthin Natural products CC(=O)OC1CC(C)(C)C(=C=CC(=CC=CC(=CC=CC=C(/C)C=CC=C(/C)C(=O)CC23OC2(C)CC(O)CC3(C)C)C)CO)C(C)(O)C1 AQLRNQCFQNNMJA-UHFFFAOYSA-N 0.000 claims description 2
- 235000012680 lutein Nutrition 0.000 claims description 2
- 239000001656 lutein Substances 0.000 claims description 2
- 229960005375 lutein Drugs 0.000 claims description 2
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims description 2
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims description 2
- 235000012661 lycopene Nutrition 0.000 claims description 2
- 239000001751 lycopene Substances 0.000 claims description 2
- 229960004999 lycopene Drugs 0.000 claims description 2
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 claims description 2
- 235000012658 paprika extract Nutrition 0.000 claims description 2
- 239000001688 paprika extract Substances 0.000 claims description 2
- 229960003471 retinol Drugs 0.000 claims description 2
- 235000020944 retinol Nutrition 0.000 claims description 2
- 239000011607 retinol Substances 0.000 claims description 2
- 229960000342 retinol acetate Drugs 0.000 claims description 2
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 claims description 2
- 235000019173 retinyl acetate Nutrition 0.000 claims description 2
- 239000011770 retinyl acetate Substances 0.000 claims description 2
- 230000009759 skin aging Effects 0.000 claims description 2
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 claims description 2
- 235000019245 violaxanthin Nutrition 0.000 claims description 2
- SZCBXWMUOPQSOX-PSXNNQPNSA-N violaxanthin Chemical compound C(\[C@@]12[C@](O1)(C)C[C@H](O)CC2(C)C)=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/[C@]1(C(C[C@@H](O)C2)(C)C)[C@]2(C)O1 SZCBXWMUOPQSOX-PSXNNQPNSA-N 0.000 claims description 2
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims description 2
- 235000010930 zeaxanthin Nutrition 0.000 claims description 2
- 239000001775 zeaxanthin Substances 0.000 claims description 2
- 229940043269 zeaxanthin Drugs 0.000 claims description 2
- 239000000284 extract Substances 0.000 description 21
- 238000004519 manufacturing process Methods 0.000 description 17
- 239000004615 ingredient Substances 0.000 description 14
- 230000003712 anti-aging effect Effects 0.000 description 13
- 239000000843 powder Substances 0.000 description 13
- 235000019441 ethanol Nutrition 0.000 description 10
- 239000006210 lotion Substances 0.000 description 10
- 241000196324 Embryophyta Species 0.000 description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 238000002156 mixing Methods 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 239000003921 oil Substances 0.000 description 9
- 239000002674 ointment Substances 0.000 description 9
- 239000000049 pigment Substances 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 229920000642 polymer Polymers 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 239000002537 cosmetic Substances 0.000 description 7
- 239000000839 emulsion Substances 0.000 description 7
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 6
- 150000001298 alcohols Chemical class 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 239000010445 mica Substances 0.000 description 5
- 229910052618 mica group Inorganic materials 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 239000003814 drug Substances 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 230000007721 medicinal effect Effects 0.000 description 4
- 230000003020 moisturizing effect Effects 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 229920003169 water-soluble polymer Polymers 0.000 description 4
- 230000037303 wrinkles Effects 0.000 description 4
- 229940058015 1,3-butylene glycol Drugs 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 3
- 239000004375 Dextrin Substances 0.000 description 3
- 229920001353 Dextrin Polymers 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 3
- 235000019437 butane-1,3-diol Nutrition 0.000 description 3
- 239000007857 degradation product Substances 0.000 description 3
- 235000019425 dextrin Nutrition 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 229930195733 hydrocarbon Natural products 0.000 description 3
- 150000002430 hydrocarbons Chemical class 0.000 description 3
- 229930014626 natural product Natural products 0.000 description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 3
- 238000007665 sagging Methods 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 230000000475 sunscreen effect Effects 0.000 description 3
- 239000000516 sunscreening agent Substances 0.000 description 3
- 229960000984 tocofersolan Drugs 0.000 description 3
- 239000001993 wax Substances 0.000 description 3
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000271566 Aves Species 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 206010014970 Ephelides Diseases 0.000 description 2
- 241000239366 Euphausiacea Species 0.000 description 2
- 235000011201 Ginkgo Nutrition 0.000 description 2
- 244000194101 Ginkgo biloba Species 0.000 description 2
- 235000008100 Ginkgo biloba Nutrition 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- 241000237852 Mollusca Species 0.000 description 2
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 229940123973 Oxygen scavenger Drugs 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- 208000012641 Pigmentation disease Diseases 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 206010064127 Solar lentigo Diseases 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000003679 aging effect Effects 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 229940073609 bismuth oxychloride Drugs 0.000 description 2
- 239000007844 bleaching agent Substances 0.000 description 2
- 235000005487 catechin Nutrition 0.000 description 2
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 2
- 230000020411 cell activation Effects 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 229950001002 cianidanol Drugs 0.000 description 2
- 239000012459 cleaning agent Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 239000003349 gelling agent Substances 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 239000004816 latex Substances 0.000 description 2
- 229920000126 latex Polymers 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- BWOROQSFKKODDR-UHFFFAOYSA-N oxobismuth;hydrochloride Chemical compound Cl.[Bi]=O BWOROQSFKKODDR-UHFFFAOYSA-N 0.000 description 2
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000019612 pigmentation Effects 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 235000013772 propylene glycol Nutrition 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000002151 riboflavin Substances 0.000 description 2
- 235000019192 riboflavin Nutrition 0.000 description 2
- 235000015170 shellfish Nutrition 0.000 description 2
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- DBSABEYSGXPBTA-RXSVEWSESA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;phosphoric acid Chemical compound OP(O)(O)=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O DBSABEYSGXPBTA-RXSVEWSESA-N 0.000 description 1
- CGFPNELNAZZYQL-RXSVEWSESA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;sulfuric acid Chemical compound OS(O)(=O)=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CGFPNELNAZZYQL-RXSVEWSESA-N 0.000 description 1
- GYDYJUYZBRGMCC-INIZCTEOSA-N (2s)-2-amino-6-(dodecanoylamino)hexanoic acid Chemical compound CCCCCCCCCCCC(=O)NCCCC[C@H](N)C(O)=O GYDYJUYZBRGMCC-INIZCTEOSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 1
- AVBJHQDHVYGQLS-UHFFFAOYSA-N 2-(dodecanoylamino)pentanedioic acid Chemical compound CCCCCCCCCCCC(=O)NC(C(O)=O)CCC(O)=O AVBJHQDHVYGQLS-UHFFFAOYSA-N 0.000 description 1
- DXANYXRZRNXGSC-UHFFFAOYSA-N 2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethyl sulfate Chemical compound CC1=C(CCOS([O-])(=O)=O)SC=[N+]1CC1=CN=C(C)N=C1N DXANYXRZRNXGSC-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- KSDSYIXRWHRPMN-UHFFFAOYSA-N 4'-O-beta-D-Galactopyranoside-6''-p-Coumaroylprunin-4',5,7-Trihydroxyflavanone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC(O)=C3C(=O)C2)C=C1 KSDSYIXRWHRPMN-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 241000205585 Aquilegia canadensis Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000086254 Arnica montana Species 0.000 description 1
- 244000003416 Asparagus officinalis Species 0.000 description 1
- 235000005340 Asparagus officinalis Nutrition 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- 235000011960 Brassica ruvo Nutrition 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 235000002568 Capsicum frutescens Nutrition 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 1
- 235000009685 Crataegus X maligna Nutrition 0.000 description 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 1
- 235000009486 Crataegus bullatus Nutrition 0.000 description 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 1
- 235000009682 Crataegus limnophila Nutrition 0.000 description 1
- 240000000171 Crataegus monogyna Species 0.000 description 1
- 235000004423 Crataegus monogyna Nutrition 0.000 description 1
- 235000002313 Crataegus paludosa Nutrition 0.000 description 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 1
- 235000017788 Cydonia oblonga Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 1
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 description 1
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 241001472120 Euphausia similis Species 0.000 description 1
- 240000000731 Fagus sylvatica Species 0.000 description 1
- 235000010099 Fagus sylvatica Nutrition 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 241000555712 Forsythia Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 241000222336 Ganoderma Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241001071795 Gentiana Species 0.000 description 1
- NGGYSPUAKQMTNP-UHFFFAOYSA-N Glabrene Chemical compound C1=C(O)C=C2OCC(C3=C4OC(C=CC4=C(O)C=C3)(C)C)=CC2=C1 NGGYSPUAKQMTNP-UHFFFAOYSA-N 0.000 description 1
- KKLOCFOZPFGVBB-UHFFFAOYSA-N Glabrene Natural products C1=C(O)C=C2OCC(C3=CC=C4OC(C=CC4=C3O)(C)C)=CC2=C1 KKLOCFOZPFGVBB-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 241000208690 Hamamelis Species 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000008694 Humulus lupulus Nutrition 0.000 description 1
- 244000025221 Humulus lupulus Species 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 240000005074 Hymenocallis caribaea Species 0.000 description 1
- 241000546188 Hypericum Species 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- YNWXJFQOCHMPCK-UHFFFAOYSA-N Isoliquiritin Natural products OC1C(O)C(O)C(CO)OC1OC(C=C1)=CC=C1C=CC(=O)C1=CC=C(O)C=C1O YNWXJFQOCHMPCK-UHFFFAOYSA-N 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- DEMKZLAVQYISIA-ONJCETCRSA-N Liquiritin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c1ccc([C@@H]2Oc3c(C(=O)C2)ccc(O)c3)cc1 DEMKZLAVQYISIA-ONJCETCRSA-N 0.000 description 1
- DEMKZLAVQYISIA-UHFFFAOYSA-N Liquirtin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-UHFFFAOYSA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 240000000982 Malva neglecta Species 0.000 description 1
- 235000000060 Malva neglecta Nutrition 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 241000183666 Nepsera aquatica Species 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241000736199 Paeonia Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 244000141353 Prunus domestica Species 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 241001529742 Rosmarinus Species 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 240000007651 Rubus glaucus Species 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- XSTYCNWRJAIPMG-UHFFFAOYSA-L S(=O)(=O)([O-])[O-].[Na+].C1(=CC=CC=C1)C=1NC2=C(N1)C=CC=C2.[Na+] Chemical compound S(=O)(=O)([O-])[O-].[Na+].C1(=CC=CC=C1)C=1NC2=C(N1)C=CC=C2.[Na+] XSTYCNWRJAIPMG-UHFFFAOYSA-L 0.000 description 1
- 235000017276 Salvia Nutrition 0.000 description 1
- 235000002953 Saxifraga stolonifera Nutrition 0.000 description 1
- 244000288377 Saxifraga stolonifera Species 0.000 description 1
- 241001247145 Sebastes goodei Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 240000001949 Taraxacum officinale Species 0.000 description 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 1
- 235000009108 Urtica dioica Nutrition 0.000 description 1
- 244000274883 Urtica dioica Species 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 1
- 241001222097 Xenocypris argentea Species 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 244000126002 Ziziphus vulgaris Species 0.000 description 1
- GZQCZDHGTYFJIF-LZWOXQAQSA-N [(2r,3s,4s)-5-(7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10-yl)-2,3,4-trihydroxypentyl] acetate Chemical compound CC(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C2=CC(C)=C(C)C=C2N=C2C1=NC(=O)NC2=O GZQCZDHGTYFJIF-LZWOXQAQSA-N 0.000 description 1
- PAUSGZCRNOTKPK-UHFFFAOYSA-N [5-hydroxy-6-methyl-4-(octanoyloxymethyl)pyridin-3-yl]methyl octanoate Chemical compound CCCCCCCC(=O)OCC1=CN=C(C)C(O)=C1COC(=O)CCCCCCC PAUSGZCRNOTKPK-UHFFFAOYSA-N 0.000 description 1
- RJDOZRNNYVAULJ-UHFFFAOYSA-L [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] Chemical compound [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] RJDOZRNNYVAULJ-UHFFFAOYSA-L 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 229940009868 aluminum magnesium silicate Drugs 0.000 description 1
- WMGSQTMJHBYJMQ-UHFFFAOYSA-N aluminum;magnesium;silicate Chemical compound [Mg+2].[Al+3].[O-][Si]([O-])([O-])[O-] WMGSQTMJHBYJMQ-UHFFFAOYSA-N 0.000 description 1
- 229940093740 amino acid and derivative Drugs 0.000 description 1
- 150000003862 amino acid derivatives Chemical class 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 239000010426 asphalt Substances 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical group C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000006229 carbon black Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 235000012730 carminic acid Nutrition 0.000 description 1
- 239000004106 carminic acid Substances 0.000 description 1
- DGQLVPJVXFOQEV-NGOCYOHBSA-N carminic acid Chemical compound OC1=C2C(=O)C=3C(C)=C(C(O)=O)C(O)=CC=3C(=O)C2=C(O)C(O)=C1[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O DGQLVPJVXFOQEV-NGOCYOHBSA-N 0.000 description 1
- 229940114118 carminic acid Drugs 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229910000423 chromium oxide Inorganic materials 0.000 description 1
- 239000002734 clay mineral Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- 235000016213 coffee Nutrition 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 230000001877 deodorizing effect Effects 0.000 description 1
- 230000003544 deproteinization Effects 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- POLCUAVZOMRGSN-UHFFFAOYSA-N dipropyl ether Chemical compound CCCOCCC POLCUAVZOMRGSN-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 229940012466 egg shell membrane Drugs 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 229960002061 ergocalciferol Drugs 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000003517 fume Substances 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 1
- 229910000271 hectorite Inorganic materials 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- YNWXJFQOCHMPCK-LXGDFETPSA-N isoliquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C=C1)=CC=C1\C=C\C(=O)C1=CC=C(O)C=C1O YNWXJFQOCHMPCK-LXGDFETPSA-N 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- DEMKZLAVQYISIA-ZRWXNEIDSA-N liquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([C@H]2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-ZRWXNEIDSA-N 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 238000000199 molecular distillation Methods 0.000 description 1
- 150000002814 niacins Chemical class 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 238000005121 nitriding Methods 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 150000003227 pyridoxines Chemical class 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 150000003287 riboflavins Chemical class 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- KJCLYACXIWMFCC-UHFFFAOYSA-M sodium;5-benzoyl-4-hydroxy-2-methoxybenzenesulfonate Chemical compound [Na+].C1=C(S([O-])(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 KJCLYACXIWMFCC-UHFFFAOYSA-M 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- CXVGEDCSTKKODG-UHFFFAOYSA-N sulisobenzone Chemical compound C1=C(S(O)(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 CXVGEDCSTKKODG-UHFFFAOYSA-N 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 229940026510 theanine Drugs 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 229960000344 thiamine hydrochloride Drugs 0.000 description 1
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 1
- 239000011747 thiamine hydrochloride Substances 0.000 description 1
- 150000003544 thiamines Chemical class 0.000 description 1
- SHWIJIJNPFXOFS-UHFFFAOYSA-N thiotaurine Chemical compound NCCS(O)(=O)=S SHWIJIJNPFXOFS-UHFFFAOYSA-N 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- 229940074410 trehalose Drugs 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- 150000003669 ubiquinones Chemical class 0.000 description 1
- 235000013799 ultramarine blue Nutrition 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
Description
【0001】
【発明の属する技術分野】
本発明は皮膚外用剤に関する。さらに詳細には、有効成分として配合されるカロチノイドやレチノイドの安定性を確保し、皮膚のくすみ、シミ、ソバカスまたは老人性色素斑及び肝斑などの色素沈着や、シワ、タルミの予防及び改善等の皮膚老化防止作用に優れた皮膚外用剤に関するものである。
【0002】
【従来の技術】
従来より、乳液、クリーム、化粧水、パック、分散液、洗浄料、軟膏、外用液等の皮膚外用剤には、これらに所定の薬効を付与することを目的として種々の薬効成分が加えられている。たとえば、皮膚のくすみ、シミ、ソバカス、老人性色素斑及び肝斑などの色素沈着や、シワ、タルミの予防及び改善等の皮膚老化の防止を目的として、ビタミンA、ビタミンEやβ―カロチン等の薬効成分が加えられている。
【0003】
しかしながら、これらの薬効成分を単に含有した皮膚外用剤では、薬効成分の効果が十分に発揮されなかったり、また、薬効成分の薬効を得るのに十分な量を添加すると安定性に欠けたり使用感が悪くなる場合があり、その改善が望まれていた。特に、カロチノイドやレチノイドは優れた皮膚老化防止作用を有することは知られていたが、製剤中に安定に配合することが難しく、これら成分を皮膚外用剤の配合成分として利用する上で隘路となっていた。
【0004】
【発明が解決しようとする課題】
従って本発明は、カロチノイドやレチノイドを製剤中で安定に配合する技術を見出し、これらを配合した優れた皮膚老化防止作用を有する皮膚外用剤を提供することを課題とするものである。
【0005】
【課題を解決するための手段】
本発明者らは、カロチノイドやレチノイドを製剤中で安定に保持しうる成分について種々検索を行っていたところ、イソステアリン酸ポリオキシエチレン硬化ヒマシ油がカロチノイドやレチノイドを安定に保つ作用を有することを見出した。そして、カロチノイドやレチノイドとイソステアリン酸ポリオキシエチレン硬化ヒマシ油とを組合せて配合すれば、カロチノイドやレチノイドの薬効が十分に発揮され、優れた皮膚老化防止作用を有する皮膚外用剤が得られることを見出し、本発明を完成した。
【0006】
すなわち本発明は、カロチノイド又はレチノイドと、イソステアリン酸ポリオキシエチレン硬化ヒマシ油とを含有することを特徴とする皮膚外用剤を提供するものである。
【0007】
【発明の実施の形態】
本発明の皮膚外用剤において、配合されるれるカロチノイド又はレチノイドとしては、アスタキサンチン、リコピン、β−カロチン、ゼアキサンチン、ルテイン、カンタキサンチン、クリプトキサンチン、ビオラキサンチン、カプサンチン、フコキサンチン、レチノール、パルミチン酸レチノール、酢酸レチノール、デヒドロレチナール及びそれらの誘導体が例示される。これらは、化学合成品であっても、また、植物、動物、微生物などの天然物から抽出されたものであってもよい。更に、天然物からこれらの物質を抽出、製造するにあたっては、その原料種類や産地は特に限定されない。
【0008】
例えば、上記のうち、アスタキサンチンとしては、例えば、以下のようにして調製されるものが好ましく利用できる。すなわち、オキアミ科オキアミ(Euphausia similis G.O.)に抽出溶媒を加え抽出し、この抽出液を瀘別してアスタキサンチン抽出物エキスを得、次いで、この抽出エキスから抽出溶媒を留去し、必要に応じて水素添加や加水分解等の化学反応を行ない、最後に、分子蒸留若しくはカラムクロマトグラフィーや高速液体クロマトグラフィー(HPLC)等の手段を用いて脱臭、精製を行なうことにより得られる精製アスタキサンチンを用いることができる。
【0009】
天然物からアスタキサンチン等のカロチノイドやレチノイドを得る場合の抽出溶媒としては、例えば低級1価アルコール(メチルアルコール、エチルアルコール、1−プロパノール、2−プロパノール、1−ブタノール、2−ブタノール等)、液状多価アルコール(グリセリン、プロピレングリコール、1,3−ブチレングリコール等)、低級アルキルエステル(酢酸エチル等)、炭化水素(ベンゼン、ヘキサン、ペンタン等)、ケトン類(アセトン、メチルエチルケトン等)、エーテル類(ジエチルエーテル、テトラヒドロフラン、ジプロピルエーテル等)、アセトニトリルなどが挙げられ、その中から1種または2種以上を用いることができ、これらの混合溶媒を用いることもできる。
【0010】
一方、本発明において用いられるイソステアリン酸ポリオキシエチレン硬化ヒマシ油は、乳化、可溶化性能に優れる非イオン界面活性剤であり、例えば、エマレックスRWIS−150、−160(日本エマルジョン社製)等の商品名で市販されている。このイソステアリン酸ポリオキシエチレン硬化ヒマシ油には、酸化エチレン付加モル数の異なるいくつかのものが提供されており、それぞれ、カロチノイドやレチノイドを安定に保持する作用を有するが、特に酸化エチレン付加モル数が40〜60であるものが特に好ましい。
【0011】
本発明の皮膚外用剤は、常法に従ってカロチノイド又はレチノイドとイソステアリン酸ポリオキシエチレン硬化ヒマシ油を適当な皮膚外用剤担体と組み合わせることにより調製される。
【0012】
皮膚外用剤の調製に当たってのカロチノイド又はレチノイドの配合量は、好ましくは0.000001〜5質量%(以下単に「%」で示す)であり、より好ましくは0.00001〜2%である。この範囲内であれば、製剤的に問題を生じることなく、高い老化防止効果を得ることができる。なお、カロチノイド又はレチノイドを含有する抽出液を使用する場合は、溶質である乾燥固形分の含有量が上記範囲内であれば良く、その抽出液濃度も何ら限定されるものではない。
【0013】
一方、本発明の皮膚外用剤におけるイソステアリン酸ポリオキシエチレン硬化ヒマシ油の配合量は、好ましくは、0.001〜2%であり、より好ましくは、0.01〜1%である。この範囲であれば、カロチノイド又はレチノイドを安定に配合することができ、かつ、高い老化防止効果を発揮することができる。
【0014】
かくして得られる本発明の皮膚外用剤には、更に必要に応じて、本発明の効果を損なわない範囲で、通常、化粧料や医薬部外品、外用医薬品等の製剤に使用される成分、例えば、水(精製水、温泉水、深層水等の他、植物などを水蒸気蒸留した際に得られる水分も含む)、油剤、界面活性剤、金属セッケン、ゲル化剤、粉体、アルコール類、水溶性高分子、皮膜形成剤、樹脂、包接化合物、抗菌剤、香料、消臭剤、塩類、pH調整剤、清涼剤、植物・動物・微生物由来の抽出物、血行促進剤、美白剤、細胞賦活剤、紫外線吸収剤、抗炎症剤、抗酸化剤、収斂剤、抗脂漏剤、保湿剤、キレート剤、角質溶解剤、酵素、ホルモン類、ビタミン類等を加えることができる。好適な成分の具体例としてはそれぞれ以下に示すものが挙げられる。ここで、「誘導体」には、形成可能な塩が含まれる。
【0015】
油剤としては、基剤の構成成分又は使用性、使用感を良くするものとして、通常の化粧料に使用されるものであれば、天然系油であるか、合成油であるか、或いは、固体、半固体、液体であるか等の性状は問わず、炭化水素類、ロウ類、脂肪酸類、高級アルコール類、エステル油、シリコーン油類、フッ素系油類等を使用することができる。好ましい油剤の例としては、スクワラン、ワセリン等の炭化水素類、ヒマシ油、ミンク油等の植物や動物由来の油脂、ミツロウ、カルナウバロウ、キャンデリラロウ、ゲイロウ等のロウ類等が挙げられる。
【0016】
ゲル化剤は、系の安定化や使用性、使用感を良くするために用いられ、N−ラウロイル−L−グルタミン酸等のアミノ酸誘導体、デキストリンパルミチン酸エステル等のデキストリン脂肪酸エステル、ショ糖脂肪酸エステル、有機変性粘土鉱物等が挙げられる。
【0017】
粉体は、主としてメーキャップ化粧料における着色や皮膚の隠蔽、又は使用感を良くするため等多目的に用いられ、通常の化粧料に使用されるものであれば、その形状(球状、針状、板状等)や粒子径(煙霧状、微粒子、顔料級等)、粒子構造(多孔質、無孔質等)を問わず、いずれのものも使用することができる。この粉体のうち、無機粉体としては、例えば、硫酸バリウム、炭酸カルシウム、タルク、雲母、合成雲母、マイカ、カオリン、セリサイト、ケイ酸、無水ケイ酸、ケイ酸アルミニウムマグネシウム、セラミックスパウダー、窒化ホウ素等が、有機粉体としては、例えば、ポリエステルパウダー、ポリエチレンパウダー、ポリスチレンパウダー、ナイロンパウダー、ラウロイルリジン等がそれぞれ挙げられる。また、粉体のうち、有色顔料としては、酸化鉄、カーボンブラック、酸化クロム、紺青、群青等の無機系顔料や、タール系色素をレーキ化したもの、天然色素をレーキ化したものが挙げられ、パール顔料としては、酸化チタン被覆雲母、酸化チタン被覆マイカ、オキシ塩化ビスマス、酸化チタン被覆オキシ塩化ビスマス、酸化チタン被覆タルク、魚鱗箔、酸化チタン被覆着色雲母等、その他タール色素、カルミン酸等の天然色素等が挙げられる。これらの粉体は、複合化したり、油剤やシリコーン又はフッ素化合物で表面処理を行なっても良い。
【0018】
アルコール類としてはエタノール、イソプロパノール等の低級アルコール、グリセリン、ジグリセリン、エチレングリコール、ジエチレングリコール、トリエチレングリコール、プロピレングリコール、ジプロピレングリコ−ル、1,3−ブチレングリコール、ポリエチレングリコール等が挙げられる。
【0019】
水溶性高分子は、系の安定化や使用性、使用感を良くするために、また保湿効果を得るために用いられる。水溶性高分子の具体例として、カラギーナン、ペクチン、寒天、ローカストビーンガム等の植物系高分子、キサンタンガム等の微生物系高分子、カゼイン、ゼラチン等の動物系高分子、デンプン等のデンプン系高分子、メチルセルロース、エチルセルロース、カルボキシメチルセルロース、ヒドロキシプロピルセルロース、ニトロセルロース、結晶セルロース等のセルロース系高分子、アルギン酸ナトリウム等のアルギン酸系高分子、カルボキシビニルポリマー等のビニル系高分子、ポリオキシエチレン系高分子、ポリオキシエチレンポリオキシプロピレン共重合体系高分子、ポリアクリル酸ナトリウム等のアクリル系高分子、ベントナイト、ヘクトライト等の無機系水溶性高分子等が挙げられる。また、この中には、ポリビニルアルコールやポリビニルピロリドン等の皮膜形成剤も含まれる。
【0020】
動物または微生物由来抽出物としては、血清除蛋白、脾臓、トリ等の卵成分、卵殻膜抽出物、鶏冠抽出物、貝殻抽出物、貝肉抽出物、ローヤルゼリー、シルクプロテイン及びその分解物又はそれらの誘導体、ヘモグロビン又はその分解物、ラクトフェリン又はその分解物、イカスミ等の軟体動物、魚肉等、鳥類、貝類、昆虫類、魚類、軟体動物類等の動物由来の抽出物、霊芝抽出物等の微生物由来の抽出物等が挙げられる。動物または微生物由来抽出物を配合することによって、保湿効果、細胞賦活効果、美白効果、抗炎症効果、活性酸素除去効果、血行促進効果等を付与することができる。
【0021】
植物抽出物としては、植物の抽出部位や、抽出方法等に特に制限はなく、例えば植物の全草、又は根、茎、幹、樹皮、幼芽、葉、花、果実、種子等から抽出することが出来、これらを乾燥、細切、圧搾、或いは発酵等、適宜処理を施し、種々の適当な溶媒を用いて低温もしくは室温〜加温下で抽出することができる。抽出溶媒としては、例えば水;メチルアルコール、エチルアルコール等の低級1価アルコール;グリセリン、プロピレングリコール、1,3−ブチレングリコール等の液状多価アルコール等の1種または2種以上を用いることができる。また、ヘキサン、アセトン、酢酸エチル、エーテル等の親油性溶媒を用いて抽出することもでき、その他、スクワラン等の油性成分等により抽出したものでも良い。得られた抽出液は濾過または吸着、脱色、精製して溶液状、ペースト状、ゲル状、粉末状とすることもできる。必要ならば、効果に影響のない範囲で更に、脱臭、脱色等の精製処理をしても良い。植物としては、アスパラガス、ノイバラ(エイジツ)、キイチゴ、クララ(クジン)、ケイケットウ、ゴカヒ、コーヒー、コメ、サイシン、サンザシ、シラユリ、シャクヤク、茶、ブナ、ブドウ、ホップ、モッカ、ユキノシタ、アルテア、アシタバ、アルニカ、インチンコウ、イラクサ、キハダ(オウバク)、オトギリソウ、スイカズラ(キンギンカ)、サルビア(セージ)、シコン、シラカバ、ムクロジ、レンゲソウ、イチョウ、オオムギ、センブリ、ナツメ(タイソウ)、ローズマリー(マンネンロウ)、オウレン、グレープフルーツ、ゲンチアナ、サボンソウ、ショウブ、ジオウ、センキュウ、ゼニアオイ(ウスベニタチアオイ)、ハマメリス、フキタンポポ、プルーン、ボダイジュ、マロニエ、マルメロ等が挙げられる。植物抽出物を配合することによって、保湿効果、細胞賦活効果、美白効果、抗炎症効果、活性酸素除去効果、血行促進効果等を付与することができる。(尚、かっこ内は、植物の別名、生薬名等を記載した。)
【0022】
抗菌剤は、ニキビなどを予防、改善する目的で用いられ、安息香酸、安息香酸ナトリウム、パラオキシ安息香酸エステル、パラクロルメタクレゾール、塩化ベンザルコニウム、フェノキシエタノール、イソプロピルメチルフェノール等が挙げられる。これらを配合することにより、ニキビなど細菌性の皮膚の炎症による色素沈着を抑制し、さらに高い老化防止効果を発揮することができる。
【0023】
活性酸素除去剤は、紫外線による過酸化脂質の生成などを抑制する目的で用いられ、スーパーオキサイドディスムターゼ、マンニトール、クエルセチン、カテキン及びその誘導体、チアミン類(チアミン塩酸塩、チアミン硫酸塩)、リボフラビン類(リボフラビン、酢酸リボフラビン等)、ピリドキシン類(塩酸ピリドキシン、ピリドキシンジオクタノエート等)、ニコチン酸類(ニコチン酸アミド、ニコチン酸ベンジル等)等のビタミンB類;ジブチルヒドロキシトルエン及びブチルヒドロキシアニソール等が挙げられる。これらの活性酸素除去剤を配合することによって、くすみを抑制し、より高い老化防止効果を発揮することができる。
【0024】
保湿剤としては、コラーゲン、エラスチン、ケラチン等のタンパク質またはそれらの誘導体、加水分解物並びにそれらの塩、ヒアルロン酸、コンドロイチン硫酸等のムコ多糖及びその誘導体、セリン、グリシン、テアニン、アスパラギン酸、アルギニン等のアミノ酸及びそれらの誘導体、ソルビトール、エリスリトール、トレハロース、イノシトール、グルコース、キシリトール、蔗糖およびその誘導体、デキストリン及びその誘導体、ハチミツ等の糖類、D−パンテノール及びその誘導体、糖脂質、セラミド等が挙げられる。これらの保湿剤を配合することにより、より高い老化防止効果を発揮し、透明感のある肌を実現することができる。
【0025】
血行促進剤は、皮膚の血流をうながすことによってメラニンの排出を促進する目的で用いられ、トウガラシチンキ、γ―オリザノール等が挙げられ、酵素としてはリパーゼ、パパイン等が挙げられる。これらを配合することにより、さらに高い老化防止効果が発揮できる。
【0026】
美白剤としては、ビタミンC及びその誘導体(L−アスコルビン酸リン酸エステル、L−アスコルビン酸硫酸エステル、ジパルミチン酸L−アスコルビル、テトライソパルミチン酸L−アスコルビル等)、グラブリジン、グラブレン、リクイリチン、イソリクイリチン及びこれらを含有するカンゾウ抽出物等が挙げられる。
【0027】
抗酸化剤としては、ビタミンEおよびその誘導体(dl−α(β、γ)−トコフェロール、酢酸dl−α−トコフェロール、ニコチン酸−dl−α−トコフェロール、リノール酸−dl−α−トコフェロール、コハク酸dl−α−トコフェロール等のトコフェロール及びその誘導体、ユビキノン類等)、ビタミンD及びその誘導体(エルゴカルシフェロール、コレカルシフェロール、ジヒドロキシスタナール等)、ルチン及びその誘導体、チオタウリン、タウリン、ハイドロキノン及びその誘導体、ヒスチジン、カテキン及びその誘導体等が挙げられる。
【0028】
抗炎症剤としては、グリチルリチン酸及びその誘導体、グリチルレチン酸及びその誘導体等が挙げられる。
【0029】
紫外線防止剤としては、パラメトキシケイ皮酸−2−エチルヘキシル、オキシベンゾン、4−tert−ブチル−4’−メトキシジベンゾイルメタン、2−ヒドロキシ−4−メトキシベンゾフェノン、2−ヒドロキシ−4−メトキシベンゾフェノン−5−スルホン酸、2−ヒドロキシ−4−メトキシベンゾフェノン−5−スルホン酸ナトリウム、2−ヒドロキシ−4−メトキシベンゾフェノン−5−硫酸ナトリウム、2−フェニルベンズイミダゾール硫酸ナトリウム、酸化チタン、酸化亜鉛等が挙げられる。また、粉体は微粒子のものを用いるとより高い効果が発揮される。
【0030】
本発明の皮膚外用剤の剤型は特に限定されず、種々の剤型、例えば、乳液、クリーム、化粧水、パック、洗浄料、メーキャップ化粧料、分散液、軟膏などの化粧料や外用医薬品等とすることができる。
【0031】
【実施例】
次に試験例及び実施例を挙げて本発明を更に詳細に説明するが、本発明はこれらになんら制約されるものではない。
【0032】
実 施 例 1
化粧水:
表1に示す処方及び下記製法で化粧水を調製した。これらの化粧水について、含有されるカロチノイドやレチノイドの安定性と、皮膚外用剤としての老化防止作用を評価した。この結果を表2、3に示す。
【0033】
( 処 方 )
【表1】
【0034】
( 製 法 )
A. 成分(1)〜(3)と(14)を混合溶解する。
B. 成分(4)〜(13)を混合溶解する。
C. 「A.」と「B.」を混合して均一にし、化粧水を得た。
【0035】
( 安定性の評価 )
カロチノイド及びレチノイドの安定性を確認するために、実施例1で得られた本発明品1,2及び比較品1〜4の化粧水を蛍光灯下に置き、14日後のカロチノイド及びレチノイドの極大吸収スペクトルを吸光度計(日立社製 U−3210)にて測定し、残存率を下記の(1)式より求めて比較・評価した。結果を表2に示す。
【0036】
【数1】
残存率(%)=(14日後の吸光度/製造直後の吸光度)×100……(1)
【0037】
( 結 果 )
【表2】
【0038】
( 老化防止作用の評価 )
被験化粧水1品につき22〜40才の女性15名をパネルとし、毎日朝と夜の2回、12週間にわたって洗顔後に被験化粧水の適量を顔面に塗布した。塗布による老化防止効果を以下の基準によって評価した。結果を表3に示す。
【0039】
評価基準:
<評 価> <内 容>
有 効 : しみやくすみ、たるみが改善された。
やや有効 : しみやくすみ、たるみがやや改善された。
無 効 : 使用前と変化なし。
【0040】
( 結 果 )
【表3】
【0041】
表2の結果に示されるように、カロチノイド(アスタキサンチンエステル)やレチノイド(パルミチン酸レチノール)にイソステアリン酸ポリオキシエチレン硬化ヒマシ油を組み合わせることにより、カロチノイド等の安定性を高めることが可能となった。また、表3の結果から、上記両成分を組み合わせた本発明品は、比較品1〜4に比べ、皮膚に適用することにより、しみやくすみ、たるみなどの老化した肌の症状を改善することができ、美しい肌とすることが明らかとなった。
【0042】
実 施 例 2
クリーム:
下記の処方及び製法でクリームを製造した。
【0043】
【0044】
( 製 法 )
A. 成分(1)〜(8)及び(10)を混合し、加熱して70℃に保つ。
B. 成分(12)の一部を加熱して70℃に保つ。
C. 「A.」に「B.」を加え、成分(12)の残部で溶解した成分 (9)及び(11)を混合した後、冷却してクリームを得た。
【0045】
実 施 例 3
乳液:
下記の処方及び製法で乳液を製造した。
【0046】
【0047】
( 製 法 )
A. 成分(12)〜(16)及び(19)を加熱混合し、70℃に保つ。
B. 成分(1)〜(11)を加熱混合し、70℃に保つ。
C. 「A.」に「B.」を加えて混合し、均一に乳化する。
D. 「C.」を冷却後、成分(17)、(18)及び成分(20)〜(22)を加え、均一に混合して乳液を得た。
【0048】
実 施 例 4
軟膏:
下記の処方及び製法で軟膏を製造した。
【0049】
【0050】
( 製 法 )
A. 成分(7)〜(9)を加熱混合し、75℃に保つ。
B. 成分(1)〜(6)を加熱混合し、75℃に保つ。
C.「A.」を「B.」に徐々に加える。
D.「C.」を冷却し、軟膏を得た。
【0051】
実 施 例 5
軟膏:
下記の処方及び製法で軟膏を製造した。
【0052】
【0053】
( 製 法 )
A. 成分(7)〜(9)の一部を加熱混合し、75℃に保つ。
B. 成分(1)〜(6)を加熱混合し、75℃に保つ。
C. 「A.」を「B.」に徐々に加える。
D. 「C.」を冷却し、軟膏を得た。
【0054】
実 施 例 6
リキッドファンデーション:
下記の処方及び製法でリキッドファンデーションを製造した。
【0055】
【0056】
( 製 法 )
A. 成分(1)〜(11)を混合溶解する。
B. 「A.」に成分(17)〜(22)を加え、均一に混合し、70℃に保つ。
C. 成分(12)〜(16)を均一に溶解し、70℃に保つ。
D. 「C.」に「B.」を添加して、均一に乳化する。
E. 「D.」を冷却後、成分(23)を添加してリキッドファンデーションを得た。
【0057】
実 施 例 7
日やけ止め乳液:
下記の処方及び製法で日焼け止め乳液を製造した。
【0058】
【0059】
( 製 法 )
A. 成分(1)〜(7)及び(9)〜(12)を混合分散する。
B. 成分(8)及び(13)〜(17)を混合分散する。
C. 「A.」に「B.」を添加して、均一に乳化し、日やけ止め乳液を得た。
【0060】
以上の実施例2〜7で得た皮膚外用剤は、それぞれ経時安定性に優れ、また皮膚に適用することにより、肌のシワ、タルミ、シミ及びくすみなどの老化防止効果に優れたものであった。
【0061】
【発明の効果】
以上説明したように、本発明の皮膚外用剤は、イソステアリン酸ポリオキシエチレン硬化ヒマシ油を使用することにより、皮膚外用剤中にカロチノイドやレチノイドを安定に含有することができるものであるため、カロチノイド等の有する、肌のシワ、タルミ、シミ及びくすみなどを防ぐという老化防止作用を十分に発揮させることのできるものである。
【0062】
従って、本発明の皮膚外用剤は、老化防止を目的とする化粧品や医薬品等、例えば、乳液、クリーム、化粧水、パック、分散液、洗浄料、軟膏、外用液等として有利に利用することができるものである。
以 上[0001]
BACKGROUND OF THE INVENTION
The present invention relates to an external preparation for skin. More specifically, the stability of carotenoids and retinoids formulated as active ingredients is secured, pigmentation such as dull skin, spots, freckles or senile pigment spots and liver spots, prevention and improvement of wrinkles and tarmi, etc. It is related with the skin external preparation excellent in the anti-skin aging effect.
[0002]
[Prior art]
Conventionally, various medicinal ingredients have been added to skin external preparations such as emulsions, creams, lotions, packs, dispersions, cleaning agents, ointments, and external liquids for the purpose of imparting a predetermined medicinal effect to them. Yes. For example, vitamin A, vitamin E, β-carotene, etc., for the purpose of preventing skin aging such as dull skin, spots, freckles, senile pigment spots and liver spots, and prevention and improvement of wrinkles and tarmi The medicinal properties are added.
[0003]
However, the topical skin preparations that simply contain these medicinal ingredients do not fully demonstrate the effects of the medicinal ingredients, and if they are added in an amount sufficient to obtain the medicinal effects of the medicinal ingredients, they may lack stability. May be worsened, and improvements have been desired. In particular, carotenoids and retinoids have been known to have an excellent anti-skin aging effect, but it is difficult to stably mix them into the preparation, which is a bottleneck in using these ingredients as ingredients for external skin preparations. It was.
[0004]
[Problems to be solved by the invention]
Accordingly, an object of the present invention is to find a technique for stably blending carotenoids and retinoids in the preparation, and to provide an external preparation for skin having an excellent anti-aging action against skin by blending these.
[0005]
[Means for Solving the Problems]
The present inventors have conducted various searches for components that can stably hold carotenoids and retinoids in the preparation, and found that polyoxyethylene hydrogenated castor oil isostearate has an action to keep carotenoids and retinoids stable. It was. It was also found that if carotenoids or retinoids are combined with polyoxyethylene hydrogenated castor oil isostearate, the medicinal effects of carotenoids and retinoids can be fully exerted, and an external skin preparation having an excellent anti-aging effect on skin can be obtained. The present invention has been completed.
[0006]
That is, the present invention provides a skin external preparation characterized by containing carotenoid or retinoid and polyoxyethylene hydrogenated castor oil isostearate.
[0007]
DETAILED DESCRIPTION OF THE INVENTION
In the skin external preparation of the present invention, the carotenoid or retinoid to be blended includes astaxanthin, lycopene, β-carotene, zeaxanthin, lutein, canthaxanthin, cryptoxanthin, violaxanthin, capsanthin, fucoxanthin, retinol, retinol palmitate, Examples are retinol acetate, dehydroretinal and their derivatives. These may be chemically synthesized products or extracted from natural products such as plants, animals, and microorganisms. Furthermore, when extracting and producing these substances from natural products, the types of raw materials and production areas are not particularly limited.
[0008]
For example, among the above, astaxanthin, for example, those prepared as follows can be preferably used. That is, extract by adding an extraction solvent to krill family krill (Euphausia similis GO), and extract this extract to obtain an astaxanthin extract extract. Then, the extraction solvent is distilled off from this extract, and hydrogenated as necessary. Finally, purified astaxanthin obtained by performing chemical reaction such as hydrolysis or hydrolysis, and finally deodorizing and purifying using means such as molecular distillation or column chromatography or high performance liquid chromatography (HPLC) can be used.
[0009]
Examples of extraction solvents for obtaining carotenoids and retinoids such as astaxanthin from natural products include, for example, lower monohydric alcohols (methyl alcohol, ethyl alcohol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, etc.), liquid many Monohydric alcohols (glycerin, propylene glycol, 1,3-butylene glycol, etc.), lower alkyl esters (ethyl acetate, etc.), hydrocarbons (benzene, hexane, pentane, etc.), ketones (acetone, methyl ethyl ketone, etc.), ethers (diethyl) Ether, tetrahydrofuran, dipropyl ether, etc.), acetonitrile, etc., and one or more of them can be used, and a mixed solvent thereof can also be used.
[0010]
On the other hand, the polyoxyethylene hydrogenated castor oil isostearate used in the present invention is a nonionic surfactant excellent in emulsification and solubilization performance, such as Emalex RWIS-150, -160 (manufactured by Nippon Emulsion Co., Ltd.), etc. It is commercially available under the trade name. This polyoxyethylene hydrogenated castor oil with stearic acid is provided with several different numbers of moles of ethylene oxide added, and each has a function of stably holding carotenoids and retinoids. Is particularly preferably 40 to 60.
[0011]
The external preparation for skin of the present invention is prepared by combining carotenoid or retinoid and polyoxyethylene isostearic acid hydrogenated castor oil with an appropriate external preparation carrier for skin according to a conventional method.
[0012]
The blending amount of the carotenoid or retinoid in the preparation of the external preparation for skin is preferably 0.000001 to 5% by mass (hereinafter simply referred to as “%”), and more preferably 0.00001 to 2%. If it is in this range, a high anti-aging effect can be obtained without causing a problem in formulation. In addition, when using the extract containing a carotenoid or a retinoid, the content of the dry solid content which is a solute should just be in the said range, and the extract concentration is not limited at all.
[0013]
On the other hand, the compounding quantity of the polyoxyethylene hydrogenated castor oil isostearate in the skin external preparation of this invention becomes like this. Preferably it is 0.001-2%, More preferably, it is 0.01-1%. If it is this range, a carotenoid or a retinoid can be mix | blended stably and the high anti-aging effect can be exhibited.
[0014]
The skin external preparation of the present invention obtained in this way is, as necessary, components that are usually used in preparations such as cosmetics, quasi-drugs, and external medicines, as long as the effects of the present invention are not impaired, for example, , Water (including purified water, hot spring water, deep water, etc., as well as water obtained by steam distillation of plants), oil agent, surfactant, metal soap, gelling agent, powder, alcohols, water-soluble Polymers, film-forming agents, resins, clathrate compounds, antibacterial agents, fragrances, deodorants, salts, pH adjusters, fresheners, extracts derived from plants, animals and microorganisms, blood circulation promoters, whitening agents, cells Activators, ultraviolet absorbers, anti-inflammatory agents, antioxidants, astringents, antiseborrheic agents, moisturizers, chelating agents, keratolytic agents, enzymes, hormones, vitamins and the like can be added. Specific examples of suitable components include those shown below. Here, “derivatives” include salts that can be formed.
[0015]
As an oil agent, it is a natural oil, a synthetic oil, or a solid oil as long as it is used for normal cosmetics as a constituent component or usability of the base, improving the feeling of use. Regardless of properties such as semi-solid or liquid, hydrocarbons, waxes, fatty acids, higher alcohols, ester oils, silicone oils, fluorine oils and the like can be used. Examples of preferable oils include hydrocarbons such as squalane and petrolatum, oils and fats derived from plants and animals such as castor oil and mink oil, waxes such as beeswax, carnauba wax, candelilla wax and gay wax.
[0016]
Gelling agents are used to improve the stability and usability of the system, and the feeling of use. Amino acid derivatives such as N-lauroyl-L-glutamic acid, dextrin fatty acid esters such as dextrin palmitate, sucrose fatty acid esters, Examples include organically modified clay minerals.
[0017]
The powder is mainly used for various purposes such as coloring in makeup cosmetics, hiding skin, or improving the feeling of use, and if it is used in normal cosmetics, its shape (spherical, needle-like, plate Shape), particle diameter (such as fumes, fine particles, pigment grade), and particle structure (porous, non-porous, etc.) can be used. Among these powders, for example, barium sulfate, calcium carbonate, talc, mica, synthetic mica, mica, kaolin, sericite, silicic acid, anhydrous silicic acid, aluminum magnesium silicate, ceramic powder, nitriding Examples of organic powders such as boron include polyester powder, polyethylene powder, polystyrene powder, nylon powder, lauroyl lysine, and the like. Among the powders, examples of colored pigments include inorganic pigments such as iron oxide, carbon black, chromium oxide, bitumen, ultramarine blue, tar pigments, and natural pigments. Pearl pigments include titanium oxide-coated mica, titanium oxide-coated mica, bismuth oxychloride, titanium oxide-coated bismuth oxychloride, titanium oxide-coated talc, fish scale foil, titanium oxide-coated colored mica, and other tar pigments and carminic acid. And natural pigments. These powders may be compounded or surface-treated with an oil agent, silicone, or fluorine compound.
[0018]
Examples of alcohols include lower alcohols such as ethanol and isopropanol, glycerin, diglycerin, ethylene glycol, diethylene glycol, triethylene glycol, propylene glycol, dipropylene glycol, 1,3-butylene glycol, and polyethylene glycol.
[0019]
The water-soluble polymer is used for stabilizing the system, improving the usability and the feeling of use, and obtaining a moisturizing effect. Specific examples of water-soluble polymers include plant polymers such as carrageenan, pectin, agar, locust bean gum, microbial polymers such as xanthan gum, animal polymers such as casein and gelatin, and starch polymers such as starch. Cellulose polymers such as methylcellulose, ethylcellulose, carboxymethylcellulose, hydroxypropylcellulose, nitrocellulose, crystalline cellulose, alginic acid polymers such as sodium alginate, vinyl polymers such as carboxyvinyl polymer, polyoxyethylene polymers, Examples thereof include polyoxyethylene polyoxypropylene copolymer-based polymers, acrylic polymers such as sodium polyacrylate, and inorganic water-soluble polymers such as bentonite and hectorite. Also included are film forming agents such as polyvinyl alcohol and polyvinyl pyrrolidone.
[0020]
Examples of extracts derived from animals or microorganisms include serum deproteinization, egg components such as spleen and birds, eggshell membrane extract, chicken crown extract, shell extract, shellfish extract, royal jelly, silk protein and their degradation products or their Microorganisms such as derivatives, hemoglobin or its degradation products, lactoferrin or its degradation products, mollusks such as squid, fish meat, birds, shellfish, insects, fish, molluscs and other animal-derived extracts, ganoderma extract The extract of origin, etc. are mentioned. By blending an animal or microorganism-derived extract, a moisturizing effect, cell activation effect, whitening effect, anti-inflammatory effect, active oxygen removal effect, blood circulation promoting effect, and the like can be imparted.
[0021]
The plant extract is not particularly limited in terms of plant extraction site, extraction method, and the like, and is extracted from, for example, whole plant plants, roots, stems, stems, bark, shoots, leaves, flowers, fruits, seeds, or the like. These can be appropriately treated, such as dried, shredded, pressed, or fermented, and extracted using various appropriate solvents at a low temperature or from room temperature to warming. As the extraction solvent, for example, water; a lower monohydric alcohol such as methyl alcohol or ethyl alcohol; or a liquid polyhydric alcohol such as glycerin, propylene glycol, or 1,3-butylene glycol can be used. . Moreover, it can also extract using lipophilic solvents, such as hexane, acetone, ethyl acetate, and ether, and what was extracted with oily components, such as squalane, may be used. The obtained extract may be filtered, adsorbed, decolored and purified to form a solution, paste, gel or powder. If necessary, purification treatment such as deodorization and decolorization may be further performed within a range not affecting the effect. Plants include asparagus, Neubara (Ages), raspberry, Clara (Kujin), caquette, gokahi, coffee, rice, saishin, hawthorn, white lilies, peonies, tea, beech, grapes, hops, mokka, yukinoshita, altea, ashitaba , Arnica, Ginseng, Nettle, Yellowfin, Hypericum, Honeysuckle (Ginkgo), Salvia (Sage), Siphon, Birch, Mulberry, Forsythia, Ginkgo, Barley, Assembly, Jujube, Rosemary , Grapefruit, gentian, savonso, shobu, jiou, senkyu, mallow (Husbenitachaoi), hamamelis, dandelion, prune, bodaiju, maronier, quince and the like. By blending a plant extract, a moisturizing effect, a cell activation effect, a whitening effect, an anti-inflammatory effect, an active oxygen removal effect, a blood circulation promoting effect and the like can be imparted. (In parentheses, plant aliases and herbal medicine names are listed.)
[0022]
Antibacterial agents are used for the purpose of preventing and improving acne and the like, and include benzoic acid, sodium benzoate, paraoxybenzoic acid ester, parachlormetacresol, benzalkonium chloride, phenoxyethanol, isopropylmethylphenol and the like. By blending these, pigmentation due to inflammation of bacterial skin such as acne can be suppressed, and a higher anti-aging effect can be exhibited.
[0023]
The active oxygen scavenger is used for the purpose of suppressing the production of lipid peroxide by ultraviolet rays, and superoxide dismutase, mannitol, quercetin, catechin and its derivatives, thiamines (thiamine hydrochloride, thiamine sulfate), riboflavins ( Riboflavin, riboflavin acetate, etc.), pyridoxines (pyridoxine hydrochloride, pyridoxine dioctanoate, etc.), nicotinic acids (nicotinic acid amide, nicotinic acid benzyl, etc.) vitamin B; dibutylhydroxytoluene, butylhydroxyanisole, etc. . By blending these active oxygen scavengers, dullness can be suppressed and a higher anti-aging effect can be exhibited.
[0024]
As moisturizing agents, proteins such as collagen, elastin, keratin or derivatives thereof, hydrolysates and salts thereof, mucopolysaccharides such as hyaluronic acid, chondroitin sulfate and derivatives thereof, serine, glycine, theanine, aspartic acid, arginine, etc. Amino acids and derivatives thereof, sorbitol, erythritol, trehalose, inositol, glucose, xylitol, sucrose and derivatives thereof, dextrin and derivatives thereof, saccharides such as honey, D-pantenol and derivatives thereof, glycolipids, ceramides and the like . By blending these moisturizers, it is possible to achieve a higher anti-aging effect and realize a transparent skin.
[0025]
The blood circulation promoter is used for the purpose of promoting melanin excretion by promoting the blood flow of the skin, such as chili pepper tincture and γ-oryzanol. Enzymes include lipase and papain. By blending these, an even higher antiaging effect can be exhibited.
[0026]
Examples of whitening agents include vitamin C and its derivatives (L-ascorbic acid phosphate, L-ascorbic acid sulfate, dipalmitic acid L-ascorbyl, tetraisopalmitic acid L-ascorbyl, etc.), grabrizine, glabrene, liquiritin, isoliquiritin And licorice extracts containing these.
[0027]
Antioxidants include vitamin E and its derivatives (dl-α (β, γ) -tocopherol, dl-α-tocopherol acetate, nicotinic acid-dl-α-tocopherol, linoleic acid-dl-α-tocopherol, succinic acid tocopherols such as dl-α-tocopherol and derivatives thereof, ubiquinones, etc.), vitamin D and derivatives thereof (ergocalciferol, cholecalciferol, dihydroxystannal etc.), rutin and derivatives thereof, thiotaurine, taurine, hydroquinone and derivatives thereof Histidine, catechin and derivatives thereof.
[0028]
Anti-inflammatory agents include glycyrrhizic acid and its derivatives, glycyrrhetinic acid and its derivatives, and the like.
[0029]
Examples of UV inhibitors include paramethoxycinnamate-2-ethylhexyl, oxybenzone, 4-tert-butyl-4′-methoxydibenzoylmethane, 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxybenzophenone- 5-sulfonic acid, 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid sodium, 2-hydroxy-4-methoxybenzophenone-5-sodium sulfate, 2-phenylbenzimidazole sodium sulfate, titanium oxide, zinc oxide, etc. It is done. Further, when the fine powder is used, a higher effect is exhibited.
[0030]
The dosage form of the external preparation for skin of the present invention is not particularly limited, and various dosage forms, for example, cosmetics such as emulsions, creams, lotions, packs, cleaning products, makeup cosmetics, dispersions, ointments, and external medicines, etc. It can be.
[0031]
【Example】
EXAMPLES Next, although a test example and an Example are given and this invention is demonstrated in detail, this invention is not restrict | limited at all.
[0032]
Example 1
Lotion:
A lotion was prepared according to the formulation shown in Table 1 and the following production method. For these lotions, the stability of the carotenoids and retinoids contained and the anti-aging effect as an external preparation for skin were evaluated. The results are shown in Tables 2 and 3.
[0033]
(How to)
[Table 1]
[0034]
(Production method)
A. Components (1) to (3) and (14) are mixed and dissolved.
B. Components (4) to (13) are mixed and dissolved.
C. “A.” and “B.” were mixed and made uniform to obtain a skin lotion.
[0035]
(Evaluation of stability)
In order to confirm the stability of carotenoids and retinoids, the lotions of the products 1 and 2 and comparative products 1 to 4 obtained in Example 1 were placed under a fluorescent lamp, and the maximum absorption of carotenoids and retinoids after 14 days. The spectrum was measured with an absorptiometer (U-3210, manufactured by Hitachi, Ltd.), and the residual ratio was obtained from the following formula (1) and compared and evaluated. The results are shown in Table 2.
[0036]
[Expression 1]
Residual rate (%) = (absorbance after 14 days / absorbance immediately after production) × 100 (1)
[0037]
(Result)
[Table 2]
[0038]
(Evaluation of anti-aging effect)
A panel of 15 females aged 22 to 40 years old for each test lotion, and a suitable amount of the test lotion was applied to the face after washing for 12 weeks twice in the morning and night every day. The anti-aging effect by application was evaluated according to the following criteria. The results are shown in Table 3.
[0039]
Evaluation criteria:
<Evaluation><Contents>
Effective: Blots, dullness and sagging were improved.
Slightly effective: Stain, dullness, and sagging were slightly improved.
Invalid: No change before use.
[0040]
(Result)
[Table 3]
[0041]
As shown in the results of Table 2, the stability of carotenoids and the like can be increased by combining carotenoids (astaxanthin esters) and retinoids (retinol palmitate) with polyoxyethylene hydrogenated castor oil isostearate. In addition, from the results of Table 3, the product of the present invention in which both the above components are combined improves the symptoms of aging skin such as spots, dullness, sagging, etc. by applying it to the skin as compared with Comparative products 1-4. It became clear that the skin was beautiful.
[0042]
Example 2
cream:
The cream was manufactured by the following prescription and manufacturing method.
[0043]
[0044]
(Production method)
A. Ingredients (1)-(8) and (10) are mixed and heated to keep at 70 ° C.
B. A portion of component (12) is heated and maintained at 70 ° C.
C. “B.” was added to “A.”, components (9) and (11) dissolved in the remainder of component (12) were mixed, and then cooled to obtain a cream.
[0045]
Example 3
Latex:
An emulsion was prepared according to the following formulation and manufacturing method.
[0046]
[0047]
(Production method)
A. Ingredients (12)-(16) and (19) are heated and mixed and maintained at 70 ° C.
B. Ingredients (1) to (11) are heated and mixed and maintained at 70 ° C.
C. Add "B." to "A.", mix and emulsify uniformly.
D. After cooling “C.”, components (17), (18) and components (20) to (22) were added and mixed uniformly to obtain an emulsion.
[0048]
Example 4
ointment:
An ointment was produced according to the following formulation and manufacturing method.
[0049]
[0050]
(Production method)
A. Ingredients (7) to (9) are heated and mixed and maintained at 75 ° C.
B. Ingredients (1) to (6) are heated and mixed and maintained at 75 ° C.
C. Gradually add “A.” to “B.”.
D. “C.” was cooled to obtain an ointment.
[0051]
Example 5
ointment:
An ointment was produced according to the following formulation and manufacturing method.
[0052]
[0053]
(Production method)
A. A part of the components (7) to (9) is heated and mixed and kept at 75 ° C.
B. Ingredients (1) to (6) are heated and mixed and maintained at 75 ° C.
C. Gradually add “A.” to “B.”.
D. “C.” was cooled to obtain an ointment.
[0054]
Example 6
Liquid foundation:
The liquid foundation was manufactured by the following prescription and manufacturing method.
[0055]
[0056]
(Production method)
A. Components (1) to (11) are mixed and dissolved.
B. Ingredients (17) to (22) are added to “A.”, mixed uniformly, and kept at 70 ° C.
C. Ingredients (12) to (16) are uniformly dissolved and maintained at 70 ° C.
D. Add "B." to "C." and emulsify uniformly.
E. After cooling “D.”, component (23) was added to obtain a liquid foundation.
[0057]
Example 7
Sunscreen latex:
A sunscreen emulsion was prepared according to the following formulation and manufacturing method.
[0058]
[0059]
(Production method)
A. Components (1) to (7) and (9) to (12) are mixed and dispersed.
B. Components (8) and (13) to (17) are mixed and dispersed.
C. “B.” was added to “A.” and emulsified uniformly to obtain a sunscreen emulsion.
[0060]
The external preparations for skin obtained in Examples 2 to 7 are each excellent in stability over time and, when applied to the skin, have excellent anti-aging effects such as skin wrinkles, tarmi, spots and dullness. It was.
[0061]
【The invention's effect】
As described above, the skin external preparation of the present invention can stably contain carotenoids and retinoids in the skin external preparation by using polyoxyethylene hydrogenated castor oil isostearate, and thus carotenoids The anti-aging effect of preventing wrinkles, tarmi, stains and dullness of the skin, etc., can be sufficiently exerted.
[0062]
Therefore, the external preparation for skin of the present invention can be advantageously used as cosmetics and pharmaceuticals for the purpose of preventing aging, for example, emulsions, creams, lotions, packs, dispersions, cleaning agents, ointments, external liquids and the like. It can be done.
more than
Claims (6)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001061534A JP3770588B2 (en) | 2001-03-06 | 2001-03-06 | Topical skin preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001061534A JP3770588B2 (en) | 2001-03-06 | 2001-03-06 | Topical skin preparation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2002265313A JP2002265313A (en) | 2002-09-18 |
| JP2002265313A5 JP2002265313A5 (en) | 2006-01-19 |
| JP3770588B2 true JP3770588B2 (en) | 2006-04-26 |
Family
ID=18920816
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001061534A Expired - Fee Related JP3770588B2 (en) | 2001-03-06 | 2001-03-06 | Topical skin preparation |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3770588B2 (en) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4526839B2 (en) * | 2004-03-05 | 2010-08-18 | 株式会社資生堂 | Method for evaluating the transparency and water retention of the stratum corneum using oxidized protein in the stratum corneum |
| FR2880803B1 (en) * | 2005-01-14 | 2007-03-09 | Secma Biotechnologies Marines | LYOPHILIZATION OF BROWN ALGAE CELLS, PROCESS FOR OBTAINING AND USES |
| GB0501365D0 (en) | 2005-01-21 | 2005-03-02 | Promar As | Compositions |
| JP2007161681A (en) * | 2005-12-16 | 2007-06-28 | Mitsui Chemicals Inc | Agent for preventing wrinkle and improving skin condition |
| JP5223083B2 (en) * | 2006-06-21 | 2013-06-26 | 国立大学法人京都大学 | Angiogenesis inhibitor |
| JP5467722B2 (en) * | 2007-01-16 | 2014-04-09 | ロート製薬株式会社 | External emulsion formulation |
| JP5109383B2 (en) * | 2007-01-31 | 2012-12-26 | 大正製薬株式会社 | Adapalene-containing external preparation composition |
| JP2008291004A (en) * | 2007-04-26 | 2008-12-04 | Oriza Yuka Kk | Skin care composition |
| WO2013002278A1 (en) * | 2011-06-28 | 2013-01-03 | 富士フイルム株式会社 | Astaxanthin-containing composition, method for manufacturing same, and cosmetic |
| WO2013125708A1 (en) * | 2012-02-24 | 2013-08-29 | 富士フイルム株式会社 | Topical skin preparation and healthy skin cell activation agent |
| CN104411368A (en) * | 2012-07-09 | 2015-03-11 | 荷兰联合利华有限公司 | A photoprotective personal care composition |
| KR102031750B1 (en) * | 2017-12-14 | 2019-10-14 | (주)진셀팜 | A cosmetic composition comprising violaxanthin |
| JP7290980B2 (en) * | 2019-03-29 | 2023-06-14 | 株式会社コーセー | Oil-in-water emulsified cosmetic |
| CN114259420A (en) * | 2021-12-29 | 2022-04-01 | 青岛黛优佳生物科技有限公司 | Cosmetic composition and preparation method thereof |
-
2001
- 2001-03-06 JP JP2001061534A patent/JP3770588B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2002265313A (en) | 2002-09-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20030005252A (en) | External preparation for the skin and beautifying agents | |
| WO2005087182A1 (en) | Functional powders | |
| JPH09143063A (en) | Composition suitable for external use | |
| JP3770588B2 (en) | Topical skin preparation | |
| JP4091824B2 (en) | Skin preparation | |
| JPH09291011A (en) | Composition suitable for eternal use | |
| JP2000256131A (en) | Tyrosinase production inhibitor and skin lotion containing the same | |
| JP2002212087A (en) | External preparation for skin | |
| JP2001031580A (en) | External preparation for skin | |
| JP3987793B2 (en) | Topical skin preparation | |
| JP2001031558A (en) | Skin lotion | |
| JP2003063925A (en) | External preparation for skin | |
| JP4015792B2 (en) | Whitening agent and external preparation for skin containing it as an active ingredient | |
| JP2002138027A (en) | External preparation for skin | |
| JP2002332224A (en) | Anti-ageing skin care preparation and anti-ageing skin care preparation composition | |
| JP2016108253A (en) | Skin-care cosmetic composition | |
| JP3754646B2 (en) | Topical skin preparation | |
| JP4203325B2 (en) | Skin external preparation and skin external preparation composition | |
| JP5863225B2 (en) | Skin care composition | |
| JP2002205916A (en) | Cosmetic | |
| JP2002265348A (en) | Composition for external use | |
| JP2007210915A (en) | Skin preparation for external use | |
| JP2002275081A (en) | Skin care preparation | |
| JP2002275018A (en) | Skin care preparation | |
| JP5198899B2 (en) | Cell activator and anti-aging skin external preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20051128 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20051128 |
|
| A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20051128 |
|
| A975 | Report on accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A971005 Effective date: 20051222 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20060110 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20060206 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 3770588 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20150217 Year of fee payment: 9 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |